Khattar Jack A.

President, CEO | Director | President &CEO

2 companies

Insider Signal Score

Good

Trades Analyzed

12M Win Rate

80.0%

Avg 3M Return

-3.7%

Avg 12M Return

+15.3%

Khattar Jack A. is a President, CEO at SUPERNUS PHARMACEUTICALS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.

Estimated insider holdings value: $65.1M based on current market prices.

Holdings by Company

SUPNOct 9, 2025

Current Shares1.27M

Value$65.00M

Net Activity-943,057

Bought: 7.2KSold: 950.3K

CGTXJun 18, 2025

Current Shares48.5K

Value$58.4K

Net Activity0

Bought: 0Sold: 0

Transaction History

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Oct 9, 2025	SUPN Supernus Pharmaceuticals, Inc.	President, CEO	Sale+OE	59,900	$50.57	$3,029,336.39	-2.4%	+3.5%	-
Oct 2, 2025	SUPN Supernus Pharmaceuticals, Inc.	President, CEO	Sale+OE	1,904	$48.06	$91,506.24	-0.2%	+3.6%	-
Oct 1, 2025	SUPN Supernus Pharmaceuticals, Inc.	President, CEO	Sale+OE	40,173	$48.07	$1,931,116.11	-3.3%	+3.9%	-
Sep 30, 2025	SUPN Supernus Pharmaceuticals, Inc.	President, CEO	Sale+OE	8,588	$48.25	$414,371.00	-0.7%	+7.2%	-
Sep 29, 2025	SUPN Supernus Pharmaceuticals, Inc.	President, CEO	Sale+OE	10,235	$48.02	$491,484.70	-0.9%	+7.7%	-
Sep 23, 2025	SUPN Supernus Pharmaceuticals, Inc.	President, CEO	Sale+OE	29,513	$47.23	$1,393,898.99	-2.5%	+10.0%	-
Sep 22, 2025	SUPN Supernus Pharmaceuticals, Inc.	President, CEO	Sale+OE	16,587	$47.02	$779,920.74	-1.5%	+9.6%	-
Sep 8, 2025	SUPN Supernus Pharmaceuticals, Inc.	President, CEO	Sale+OE	6,322	$46.29	$292,645.38	-0.6%	+2.9%	-
Sep 5, 2025	SUPN Supernus Pharmaceuticals, Inc.	President, CEO	Sale+OE	55,578	$46.01	$2,557,143.78	-4.8%	-2.0%	-
Aug 28, 2025	SUPN Supernus Pharmaceuticals, Inc.	President, CEO	Sale+OE	34,800	$45.10	$1,569,430.50	-1.6%	+2.0%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC